The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.
- Past awards
- 8
- 8 new
- Median first-year cost
- $601,506
- $4,294,698 in all
- Institutions
- 7
- 8 contact PIs
- Patents
- 3
- from 1 funded project
Awards by fiscal year
Fiscal years 2014 to 2026.
Most frequent institutions
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO2
- BAYLOR COLLEGE OF MEDICINE1
- BOSTON CHILDREN'S HOSPITAL1
- ROCKEFELLER UNIVERSITY1
- SCRIPPS RESEARCH INSTITUTE, THE1
and 2 other institutions
Most frequent study sections
- Special Emphasis Panel (ZNS1 SRB-J (16))8
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| FY2018 | Natural products as probes of the pain pathway1R35NS105038-01 | Julius, David | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | First-year cost $796,695 | Study section ZNS1 |
| FY2018 | Glial control of neuron development and function1R35NS105094-01 | Shaham, Shai | ROCKEFELLER UNIVERSITY, NY | First-year cost $760,908 | Study section ZNS1 |
| FY2018 | Mechanisms of force sensing in the nervous system1R35NS105067-01 | Patapoutian, Ardem | SCRIPPS RESEARCH INSTITUTE, THE, CA | First-year cost $677,250 | Study section ZNS1 |
| FY2018 | Preclinical development of breakthrough immunotherapy for brain tumors1R35NS105068-01 | Okada, Hideho | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | First-year cost $601,887 | Study section ZNS1 |
| FY2018 | Molecular Mechanisms of Drug Resistance in Primary Brain Tumors1R35NS105109-01 | Mellinghoff, Ingo K | SLOAN-KETTERING INST CAN RESEARCH, NY | First-year cost $601,125 | Study section ZNS1 |
| FY2018 | The biophysics of skin-neuron sensory tactile organs and their sensitivity to mechanical and chemical stress1R35NS105092-01 | Goodman, Miriam B | STANFORD UNIVERSITY, CA | First-year cost $448,300 | Study section ZNS1 |
| FY2018 | STRUCTURAL VARIATION IN NEUROLOGICAL DISEASE1R35NS105078-01 | Lupski, James R. | BAYLOR COLLEGE OF MEDICINE, TX | First-year cost $345,165 | Study section ZNS1 |
| FY2018 | Unravelling mechanisms and novel therapeutic targets for peripheral neuropathy and neuropathic pain1R35NS105076-01 | Woolf, Clifford J | BOSTON CHILDREN'S HOSPITAL, MA | First-year cost $63,368 | Study section ZNS1 |
Patents from its funded projects
3 patents name 1 of the 8 funded projects.
- US 12,636,345 (opens the patent at USPTO, a PDF, in a new tab)METHODS OF TREATING GLIOBLASTOMASGranted May 26, 2026 to THE REGENTS OF THE UNIVERSITY OF CALIFORNIAR35NS105068 · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA
- US 12,144,826 (opens the patent at USPTO, a PDF, in a new tab)METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMASGranted November 19, 2024 to THE REGENTS OF THE UNIVERSITY OF CALIFORNIAR35NS105068 · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA
- US 12,090,170 (opens the patent at USPTO, a PDF, in a new tab)METHODS OF TREATING GLIOBLASTOMASGranted September 17, 2024 to THE REGENTS OF THE UNIVERSITY OF CALIFORNIAR35NS105068 · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA
Each number opens the patent at USPTO, beside the project NIH ties it to and that project's institution. NIH ties a patent to a project, not to a year of its funding, and says its list is incomplete. The grant date and the owners are USPTO's: the organizations the patent names as assignees on the day it was granted. Source: United States Patent and Trademark Office, www.uspto.gov, which does not endorse ScienceDex.
Data: Grants.gov's daily extract and NIH's notice pages, award files and patents file, in ScienceGraph release conductgrants-2026-11-13-0.3.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.